GlassScriptPhysician profile
John A Zavala
NPI 1790973121
$2,172.10
in general payments reported to CMS, 2019-2025
20 companies · $512 in 2025
The $512 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $58.38 · 2021: $591 · 2022: $528 · 2023: $85.87 · 2024: $95.53 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $413.90 | 2021-2022 | |
| Bioventus LLC | $264.25 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System, Xcell |
| Zimmer Biomet Holdings, INC. | $235.68 | 2021-2022 | |
| Smith+Nephew, INC. | $229.33 | 2020-2025 | Real Intelligence |
| Pylant Medical | $228.93 | 2019-2022 | |
| Restor3d, INC. | $171.03 | 2025 | |
| Trice Medical, INC. | $123.75 | 2019 | |
| Abbott Laboratories | $107.01 | 2021-2022 | |
| Depuy Synthes Sales INC. | $95.29 | 2021-2024 | Orthovisc, Monovisc |
| Horizon Therapeutics Plc | $45.30 | 2022-2023 | Krystexxa |
| Acclarent, INC | $41.47 | 2023 | Trudi Nav Cable |
| Pacira Pharmaceuticals Incorporated | $31.86 | 2025 | Iovera, Zilretta, Exparel |
| Orthofix Medical, INC. | $29.93 | 2021-2022 | |
| Orthalign INC | $28.95 | 2020 | |
| Stryker Corporation | $26.27 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $25.57 | 2019 | |
| Biotissue Holdings INC. | $22.58 | 2022 | |
| Amgen INC. | $18.65 | 2025 | Krystexxa |
| Ermi LLC | $17.64 | 2019 | |
| Axogen | $14.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Zavala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.